- Dividend Brief
- Posts
- The EV Power Shift Just Took Another Big Step Forward
The EV Power Shift Just Took Another Big Step Forward
A major new partnership highlights how quickly the balance of power in electric vehicles is changing as legacy automakers scramble to stay competitive.
The global auto industry is starting to look very different. And for traditional carmakers, adapting to the EV era is becoming less about choice and more about survival.
Read on for everything you need to know about a major new alliance that could see one automaker taking pole position.
Elite Picks (Sponsored)
This report focuses on a narrow group of stocks identified through a detailed screening process.
Analysts apply a combination of metrics to narrow down potential opportunities.
Past selections have shown strong momentum, but no outcomes are guaranteed.
The newest edition is now open for access.
Get the report now
Pharma
Amgen Is Setting Up Its Next Growth Engine
Amgen (NASDAQ: AMGN) just made a major strategic move that goes beyond routine updates.
The company is expanding late-stage trials of its obesity drug MariTide, including new studies to switch patients from existing treatments and test less frequent dosing schedules.
The timing matters because Amgen is entering a phase in which its older products are facing pressure. Building the next wave is no longer optional; it is critical.
A New Flagship Is Being Built
MariTide is being shaped as more than just another drug. The focus on fewer injections and easier patient transitions shows Amgen is trying to stand out in a highly competitive space.
What stands out to you is how the company is designing this product to win on convenience as much as effectiveness.
That positioning matters, since simplicity and usability often decide which treatments gain traction.
Preparing for What’s Coming
Pharma companies operate in cycles in which major drugs eventually face competition. Amgen is clearly preparing for that shift by accelerating development of its next potential blockbuster.
Your takeaway aligns with how seriously Amgen is treating the transition phase, investing early to avoid a growth gap.
A Bigger Direction Is Locking In
The expansion of trials shows commitment, not experimentation. Amgen is aligning resources, research, and long-term planning around a new core product.
You get a company actively building its next chapter, where future success depends on how well this new generation of treatments performs.
AMGN currently trades at $331.00 and pays a dividend of $10.08 per share, a yield of 3.05%.
Retail
The World’s Biggest Sports Brand Is Cleaning House
Nike (NYSE: NKE) is going through one of its biggest internal resets in years. The company is pulling back from heavy discounting, cutting down excess inventory, and refocusing on fewer, stronger product launches.
This is not a minor adjustment; it is a full rethink of how Nike sells, markets, and positions its brand.
From Volume to Value
Nike had been pushing volume, often relying on discounts to move products. That approach worked short-term, but started to hurt brand perception over time.
What stands out to you is the shift toward selling fewer products at full price rather than chasing constant sales.
Fixing What Slipped
The company is also reworking its product lineup. Older franchises are being scaled back while innovations in running, football, and basketball are getting more focus.
At the same time, Nike is rebuilding relationships with retail partners after leaning heavily into direct sales.
From your perspective, it comes down to how Nike is rebalancing control and reach after leaning too heavily one way.
A Bigger Direction Is Taking Shape
Nike is not just adjusting inventory; it is rebuilding how it shows up in the market. Cleaner product lines, stronger storytelling, and tighter execution are all part of the shift.
The direction is locking in. You are looking at a company trying to reclaim its premium status, where brand strength matters more than short-term sales spikes.
NKE currently trades at $42 and pays a dividend of $1.64 per share, a yield of 3.90%.
IPO Watch (Sponsored)
Bloomberg is calling Elon Musk's upcoming SpaceX IPO "the biggest listing of ALL TIME."
But here's the thing - most investors will be locked out until AFTER it goes public.
Not you.
I've found a 'backdoor' that lets everyday Americans grab a pre-IPO stake in SpaceX right now.
Click Here for the FREE "SpaceX" Ticker
Logistics
FedEx Just Made a Big Call as Its Core Business Gets Tested
FedEx (NYSE: FDX) just made a major move by accelerating the consolidation of its delivery network, bringing together parts of its Express and Ground operations into a more unified system.
The change is not cosmetic. It touches how packages move through the entire system, from sorting facilities to last-mile delivery.
A Network Built for Yesterday Is Being Reworked
FedEx built separate networks for different types of deliveries. That worked when demand was stable and clearly segmented.
What stands out to you is how that structure is now being simplified into one system that can handle mixed demand more efficiently.
That shift is operationally heavy. It requires rethinking routes, facilities, and how capacity is used every day.
Cost Pressure Is Forcing Action
Shipping customers are pushing for lower prices while expecting faster delivery. At the same time, volume patterns are no longer consistent enough to support older cost structures.
A unified network gives FedEx more flexibility. It allows the company to adjust capacity faster and reduce inefficiencies across operations.
The direction is locking in. You now have a company rebuilding its logistics engine to keep up with a demand environment where flexibility matters as much as scale.
FDX currently trades at $371 and pays a dividend of $5.80 per share, a yield of 1.56%.
Dividend Stocks Worth Watching
Target Corporation (NYSE: TGT) is rolling out baby boutiques across hundreds of stores as part of a broader effort to win back young families and revive sales growth after several difficult years.
Target is leaning harder into higher-value family shoppers, a group that visits more frequently and spends significantly more than the average customer.
By adding premium baby brands, improving store presentation, and expanding convenience services, the retailer is trying to rebuild loyalty in an area where competitors like Walmart and Amazon have been gaining ground.
This is also about repositioning the brand.
Target is attempting to move beyond being viewed primarily as a value retailer and instead become a more trusted one-stop destination for busy households willing to spend more for convenience, quality, and experience.
For dividend investors, the story is firmly tied to execution. Management believes sales growth can return this year, and early traffic data is showing some improvement.
If Target can successfully reconnect with higher-spending families while improving store momentum, it could strengthen both revenue stability and long-term shareholder returns.
TGT pays a $1.14 dividend, yielding 3.80%.
The Kraft Heinz Company (NYSE: KHC) is using Kool-Aid to push deeper into the fast-growing hydration market, launching new electrolyte drink packets aimed at consumers who want healthier options without premium pricing.
The broader strategy here ties into the food manufacturer’s push to modernize legacy brands that have struggled for years as consumers shifted toward fresher, lower-sugar, and more functional food and drink options.
Kool-Aid Hydration, along with newer Capri Sun and Kraft Mac & Cheese spin-offs, signals a much larger effort to reposition the company around shifting health and wellness trends.
There is also a pricing angle at play. The hydration category has exploded in recent years, but many leading brands sit at premium price points.
Kraft Heinz sees an opportunity for more affordable electrolyte products that still appeal to consumers seeking cleaner ingredients, lower sugar, and functional benefits.
For dividend investors, this is a turnaround story built around brand reinvention.
Kraft Heinz is betting that familiar household names still carry enough consumer loyalty to compete in newer health-focused categories, but the key will be whether innovation can finally translate into sustained sales growth after years of stagnation.
KHC pays a 40-cent dividend, yielding 6.89%.
Stellantis N.V. (NYSE: STLA) is deepening its partnership with Chinese EV maker Leapmotor in a move that could signal a major shift in how European automakers compete in the electric vehicle market.
Highlighting how urgently legacy carmakers are trying to adapt to the EV transition, Stellantis is expected to use the partnership to gain faster access to competitive EV technology and lower-cost development, while also helping Leapmotor establish a manufacturing footprint inside Europe and sidestep tariff pressures.
This is becoming a much bigger industry trend.
Western automakers are facing rising costs, slowing demand, regulatory pressure, and fierce competition from Chinese EV brands that have moved ahead in affordability and software.
Partnerships like this are increasingly seen as less optional and more necessary for traditional automakers trying to stay competitive.
For dividend investors, the question is whether Jeep-owner Stellantis can turn these alliances into a long-term advantage without weakening its own brands or strategic position.
The company is attempting to balance short-term survival in a difficult market with the much larger challenge of remaining relevant in the next generation of automotive manufacturing.
STLA pays a 68-cent annual dividend, yielding 10.10%.
Dividend Increases
AU has lifted its dividend to $1.16, up 570.52%. Its new yield is 4.33%.
PKG has grown its dividend to $1.50, an increase of 20.00%. Its new yield is 2.73%.
ICL has increased its dividend to 5 cents, up 15.1%. Its new yield is 3.35%.
SFL has increased its dividend to 22 cents, a rise of 10.00%. Its new yield is 6.87%.
HBB has raised its dividend to 12 cents, a boost of 4.17%. Its new yield is 2.39%.
Dividend Decreases
B has cut its dividend to 17 cents, a decline of 58.33%. Its new yield is 1.49%.
Quiet Signals (Sponsored)
A potential executive order tied to financial policy is drawing attention from market watchers.
Moves of this scale can ripple across currencies, savings, and hard assets.
With renewed focus on gold reserves and valuation, some believe a major shift could be unfolding.
Understanding the implications early may be key.
Learn how this could impact your strategy
Trivia: How much did S&P 500 companies collectively pay out in dividends in 2023? |
Upcoming Dividend Payers
CL’s ex-dividend date for the forthcoming 53-cent payment is 05/15/26.
MAIN’s ex-dividend date for the forthcoming 26-cent payment is 05/15/26.
UNM’s ex-dividend date for the forthcoming 46-cent payment is 05/15/26.
EWBC’s ex-dividend date for the forthcoming 80-cent payment is 05/18/26.
RWWI’s ex-dividend date for the forthcoming 25-cent payment is 05/18/26.
Everything Else
SpaceX is targeting a June IPO at a potential $1.5 trillion valuation and a free report names seven space stocks positioned to look deeply undervalued the moment it debuts.
Hormel Foods is expanding its Herdez brand of Mexican products with a new Asada collection featuring marinades, sauces, and seasonings.
Tanger is adding to its portfolio of malls around the US with the purchase of The Town Center at Levis Commons, an open-air mall in Perrysburg, Ohio.
Morgan Stanley has appointed a new head of operations in Scotland. Angela McCann will step up to support the international bank across its global operations from the firm’s base in Glasgow.
That’s all for today’s edition of the Dividend Brief.
Thanks for reading, and if you have any feedback or dividend stocks you want me to take a look at, just reply to this email!
—Noah Zelvis
DividendBrief.com